QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intel-moderna-and-dollar-general-were-among-top-10-large-cap-losers-in-august-are-the-others-in-your-portfolio

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fie...

 magnificent-7-miss-out-2-cybersecurity-stocks-stand-firm-retailers-lag-in-volatile-august-here-are-the-top-sp-500-gainers-and-losers

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

 td-cowen-maintains-hold-on-charles-river-lowers-price-target-to-203

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Hold and lowers the price target from $228 to $203.

 warner-bros-airbnb-and-monster-beverage-are-among-top-10-large-cap-losers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. be...

 barclays-maintains-equal-weight-on-charles-river-lowers-price-target-to-210

Barclays analyst Luke Sergott maintains Charles River (NYSE:CRL) with a Equal-Weight and lowers the price target from $230 t...

 ubs-maintains-buy-on-charles-river-lowers-price-target-to-240

UBS analyst Dan Brennan maintains Charles River (NYSE:CRL) with a Buy and lowers the price target from $290 to $240.

 evercore-isi-group-maintains-outperform-on-charles-river-lowers-price-target-to-225

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and lowers the price target from ...

 goldman-sachs-maintains-buy-on-charles-river-lowers-price-target-to-250

Goldman Sachs analyst Matthew Sykes maintains Charles River (NYSE:CRL) with a Buy and lowers the price target from $290 to $...

 jp-morgan-downgrades-charles-river-to-neutral-lowers-price-target-to-205

JP Morgan analyst Casey Woodring downgrades Charles River (NYSE:CRL) from Overweight to Neutral and lowers the price target ...

 baird-downgrades-charles-river-to-neutral-lowers-price-target-to-191

Baird analyst Eric Coldwell downgrades Charles River (NYSE:CRL) from Outperform to Neutral and lowers the price target from ...

 wall-street-ends-wednesday-in-the-red-as-risk-sentiment-remains-fragile-sp-500-movers-at-the-close

U.S. markets close lower on Wednesday after bounce back on Tuesday, with small caps hit hardest. Investors assess economic outl...

 charles-river-laboratories-stock-sinks-as-it-warns-of-continued-biotech-demand-slump-lowers-forecast

Charles River Laboratories reported Q2 2024 revenue of $1.03 billion, a 3.2% decrease year-over-year, surpassing the $1.024 bil...

 charles-river-q2-2024-adj-eps-280-beats-239-estimate-sales-103b-beat-1024b-estimate

Charles River (NYSE:CRL) reported quarterly earnings of $2.80 per share which beat the analyst consensus estimate of $2.39 by 1...

 charles-river-and-autobahn-labs-establish-partnership-to-accelerate-academic-discoveries-into-novel-therapeutics-charles-river-to-make-equity-investment-in-autobahn-labs-chief-scientific-officer-justin-bryans-named-to-autobahns-board-of-directors

Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capab...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION